[Use of buprenorphine as a cornerstone in narcosis and as analgesic in the postoperative period in gynecologic surgery].
In a clinical trial buprenorphine (0.3 mg i.v.) was administered, 20-45 minutes before the surgical operation, to 220 women undergoing gynecological surgery. If necessary buprenorphine (0.2-0.3 mg i.m.) was administered also in the post-operative period. By the pre-operatory administration of buprenorphine, a great stability of life parameters was observed during the surgical operation. In the post-operative period most of the patients showed absence of pain or mild pain.
Lodoli
L
L
Ponzi
S
S
Scaricabarozzi
I
I
D000698:Analgesia; D000758:Anesthesia; D002047:Buprenorphine; D005260:Female; D005836:Genitalia, Female / Q000601:surgery*; D006801:Humans; D010149:Postoperative Pain / Q000188:drug therapy; D011292:Premedication
D002047:Buprenorphine
Impiego della buprenorfina come agente cardine della narcosi e come analgesico nel post-operatorio in chirurgia ginecologica.